title: AstraZeneca's response to the review by Wysowski and Pollock regarding deaths reported in association with propofol use.
authors.forename: Kjell
authors.initials: K
authors.lastname: Ahlen
authors.forename: Christopher
authors.initials: C
authors.lastname: Buckley
authors.forename: A Hugh
authors.initials: AH
authors.lastname: Pulsford
mesh_terms: D000328:Adult; D000771:Anesthesia, Intravenous / Q000401:mortality*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D004345:Drug Industry; D006801:Humans; D019586:Intracranial Hypertension / Q000188:drug therapy; D015742:Propofol / Q000008:administration & dosage / Q000009:adverse effects*; D013226:Status Epilepticus / Q000188:drug therapy
chemical_list: D018686:Anesthetics, Intravenous; D015742:Propofol